Yuxin Liu

5PUBLICATIONS
73CO-AUTHORS
Molecular targetsGene and molecular therapyRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 30, 2025
Mezigdomide for multiple myeloma: a focus on phase 2 trial data.

Clifton C Mo, Yuxin Liu, Omar Nadeem

|Aug 08, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.

Beatrice M Razzo, Shonali Midha, Andrew J Portuguese

|Jul 09, 2025
Real-World Experience with Teclistamab for Relapsed/Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium.

Beatrice M Razzo, Shonali Midha, Andrew J Portuguese

|Sep 27, 2021
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions.

Victor Manuel Orellana-Noia, Daniel R Reed, Ashley Alesia McCook

|May 29, 2019
Prolonged Response to Pembrolizumab in Spindle Cell Squamous Cell Carcinoma Metastatic to the Central Nervous System.

Yuxin Liu, Bailey Fitzgerald, Edward Perry

Pageof 1